TRCT
LHDX

Tower Research Capital (TRC)’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Tower Research Capital (TRC)’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,972
Closed -$1K – 6671
2022
Q4 		$1K Buy
12,972
+9,422
+265% +$6.01K ﹤0.01% 5796
2022
Q3 		$4K Buy
+3,550
New +$8.09K ﹤0.01% 5334
2022
Q1 		– Sell
-169
Closed -$1K – 6935
2021
Q4 		$1K Buy
+169
New +$1.07K ﹤0.01% 5994
2021
Q3 		– Sell
-4,402
Closed -$30K – 6404
2021
Q2 		$30K Buy
4,402
+3,118
+243% +$19.7K ﹤0.01% 3506
2021
Q1 		$16K Buy
+1,284
New +$25.5K ﹤0.01% 4077

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return